Taevas
BangladeshPharmaceuticals
Warehousing & Inventory
Warehousing & Inventory for Pharmaceuticals in Bangladesh
Taevas Global delivers DGDA-compliant warehousing and inventory management that gives pharmaceuticals manufacturers a secure, audit-ready foothold in one of South Asia's fastest-growing drug markets. From temperature-controlled storage to real-time stock
Market
Bangladesh
Industry
Pharmaceuticals
Service
Warehousing & Inventory
Regulator
Directorate General of Drug Administration (DGDA)
Timeline
4-6 Weeks
What We Deliver
Six Pillars of Bangladesh Pharmaceuticals Intelligence
Our six interconnected pillars give pharmaceuticals companies the regulatory grounding, operational infrastructure, and market intelligence needed to warehouse and distribute drugs compliantly across Bangladesh.
01
DGDA Regulatory Compliance
We map every warehousing obligation under the Drugs Act 1940 and DGDA Good Storage Practice guidelines so your facility meets inspection standards from day one. Our compliance team tracks circular updates and ensures your documentation, labelling, and storage conditions align with current DGDA requirements. Non-compliance risks product seizure and licence suspension, making this pillar foundational to every other element of your Bangladesh operation.
Good Storage Practice audit readiness
DGDA drug licence and import permit alignment
Continuous regulatory change monitoring
How It Works
From Brief to Board-Ready Intelligence
Our four-step engagement takes you from initial scoping to a fully operational, DGDA-compliant warehousing setup with the market intelligence your leadership team needs to commit capital confidently.
Step 1 · Day 1-2
Discovery & Requirements Scoping
We conduct a structured intake session with your supply chain, regulatory, and commercial teams to document your product portfolio, temperature requirements, import volumes, and target launch timeline. This session maps your existing global SOPs against DGDA warehousing requirements and identifies the critical gaps that must be resolved before first shipment. The output is a scoping brief that anchors the entire engagement.
Taevas Approach
The scoping session covers product classifications under DGDA schedules, estimated SKU count, cold-chain tier requirements, initial import volumes, preferred warehouse locations, and any existing Bangladesh regulatory filings. We also capture your internal approval thresholds so deliverables are calibrated to your decision-making process from the start.
Market Snapshot
Bangladesh Pharmaceuticals Market at a Glance
$0B+
Pharmaceuticals Market Size
0%
Annual Market Growth Rate
0+
Licensed Manufacturers
0+
DGDA Registered Drug Products
Domestic Manufacturing Dominance
Bangladesh's pharmaceutical industry is one of the most self-sufficient in the developing world, with domestic manufacturers supplying approximately 98 percent of local demand. This creates a highly competitive pricing environment for foreign entrants who must position on differentiation, including novel formulations, biologics, or oncology products not yet produced locally. Understanding this competitive landscape is essential before committing to a warehousing and distribution investment.
DGDA Regulatory Stringency
The Directorate General of Drug Administration enforces Good Manufacturing Practice and Good Storage Practice standards that have become progressively stricter as Bangladesh positions its industry for export growth. Foreign companies must obtain DGDA import registration for each product and ensure their warehousing partners hold valid DGDA facility licences. Regulatory non-compliance can result in product seizure, import bans, and reputational damage that is difficult to reverse in a relationship-driven market.
Export-Oriented Growth Trajectory
Bangladesh currently exports pharmaceuticals to over 150 countries and is actively seeking WHO prequalification for more products to access regulated markets. This export ambition is driving infrastructure investment in GMP-certified manufacturing and cold-chain logistics that foreign companies can leverage for their own in-country storage needs. The government's Vision 2041 industrial policy explicitly supports pharmaceutical sector expansion, signalling sustained regulatory and infrastructure investment.
Cold Chain Infrastructure Gap
Despite rapid industry growth, Bangladesh's cold-chain logistics infrastructure remains underdeveloped relative to the volume of temperature-sensitive products now entering the market, including insulin, vaccines, and biosimilars. Power reliability outside Dhaka and Chittagong is inconsistent, creating real risk of temperature excursions during last-mile distribution. Pharmaceuticals companies entering Bangladesh must build cold-chain redundancy into their warehousing design from the outset rather than relying on standard 3PL infrastructure.
What's Included
Everything in Your Report
Every Taevas Global warehousing and inventory engagement for Bangladesh pharmaceuticals produces eight structured deliverables that give you the documentation, intelligence, and operational assets to move from decision to execution.
DGDA Compliance Gap Report
A detailed audit of your current regulatory position against DGDA Good Storage Practice requirements, with a prioritised remediation roadmap and estimated timeline for each gap.
Warehouse Facility Assessment
Physical and documentation assessment of shortlisted Bangladesh warehouse facilities against a 47-point DGDA GSP checklist, with a scored comparison and recommended selection.
Cold Chain Design Blueprint
A validated cold-chain architecture covering temperature zone specifications, equipment selection, monitoring protocols, and contingency procedures for power outages and equipment failure.
Import & Customs Roadmap
A step-by-step guide to DGDA import registration, NBR customs classification, applicable duty rates, and Chittagong Port clearance procedures for your specific product categories.
Warehouse Network Location Map
A geo-mapped analysis of optimal warehouse locations across Dhaka, Chittagong, and secondary cities, with distribution reach overlays and 3PL provider shortlists.
Standard Operating Procedures Pack
A full set of DGDA-aligned SOPs for receiving, storage, picking, dispatch, temperature monitoring, and product recall, produced in English and Bengali.
Demand Planning Model
A Bangladesh-specific demand model incorporating seasonal disease patterns, government tender cycles, and essential medicines list volumes to right-size your opening stock and reorder parameters.
Regulatory Calendar & Monitoring Brief
A 12-month forward calendar of DGDA licence renewals, inspection windows, and regulatory change triggers, with a monitoring brief covering the key policy developments to watch.
Who This Is For
Built for These Situations
Market Entry
Foreign Pharmaceuticals Manufacturer Entering Bangladesh
You are a mid-to-large pharmaceuticals manufacturer outside Bangladesh that has identified the market as a priority for export or local distribution and needs to establish a compliant, operational warehousing presence quickly. You have no existing in-country infrastructure, limited familiarity with DGDA requirements, and need a partner who can compress the setup timeline without cutting compliance corners. Your board has approved the market entry but requires a clear operational plan before releasing capital.
Outcome
A fully operational, DGDA-compliant warehouse with validated cold chain, trained local staff, and live inventory visibility within six weeks of engagement start.
Next Steps
After Warehousing & Inventory, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your Bangladesh Opportunity?
Whether you are planning your first pharmaceutical shipment into Bangladesh or need to bring an existing warehousing operation into DGDA compliance, Taevas Global has the in-country expertise and regulatory knowledge to move you forward with confidence. Request a proposal today and speak with a specialist within 48 hours.
DGDA-compliant warehousing setup in 4-6 weeks
Validated cold chain design for tropical conditions
End-to-end import and customs coordination
Ongoing regulatory monitoring and compliance support